Metallodrugs in cancer nanomedicine

Peña, Quim; Wuttke, Stefan; Molto Pallares, Roger; Zaremba, Orysia; Wang, Alec; Metselaar, Josbert M.; Kiessling, Fabian; Shi, Yang; Lammers, Twan; Scheeren, Hans W.

doi:SCOPUS:2-s2.0-85126931239

Metallodrugs in cancer nanomedicine

Peña, Quim (Corresponding author)^RWTH* ; Wang, Alec^RWTH* ; Zaremba, Orysia ; Shi, Yang^RWTH* ; Scheeren, Hans W.^RWTH* ; Metselaar, Josbert M.^RWTH* ; Kiessling, Fabian^RWTH* ; Molto Pallares, Roger^RWTH* ; Wuttke, Stefan (Corresponding author) ; Lammers, Twan (Corresponding author)^RWTH*

In
Chemical Society reviews : CSR 51(7), Seiten/Artikel-Nr.:2544-2582

2022

ImpressumLondon : The Royal Society of Chemistry

ISSN0306-0012

Online
DOI: 10.1039/D1CS00468A
10.1039/D1CS00468A

Einrichtungen

Thematische Einordnung (Klassifikation)
DDC: 540

Dokumenttyp
Journal Article

Format
online, print

Sprache
English

Anmerkung
Peer reviewed article

Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85126931239
WOS Core Collection: WOS:000765902400001
PubMed: pmid:35262108

Interne Identnummern
RWTH-2022-10094
Datensatz-ID: 855228

Beteiligte Länder
Germany, Spain

Lizenzstatus der Zeitschrift

; Allianz-Lizenz / DFG ; BIOSIS Previews ; BIOSIS Reviews Reports And Meetings ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 40 ; IF >= 60 ; JCR ; National-Konsortium ; National-Konsortium ; Nationallizenz